Cargando…
Do fetal extravillous trophoblasts circulate in maternal blood postpartum?
INTRODUCTION: Circulating fetal extravillous trophoblasts may offer a superior alternative to cell‐free fetal DNA for noninvasive prenatal testing. Cells of fetal origin are a pure source of fetal genome; hence, unlike the cell‐free noninvasive prenatal test, the fetal cell‐based noninvasive prenata...
Autores principales: | van de Looij, Anne, Singh, Ripudaman, Hatt, Lotte, Ravn, Katarina, Jeppesen, Line D., Nicolaisen, Bolette H., Kølvraa, Mathias, Vogel, Ida, Schelde, Palle, Uldbjerg, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384123/ https://www.ncbi.nlm.nih.gov/pubmed/32323316 http://dx.doi.org/10.1111/aogs.13880 |
Ejemplares similares
-
The Number of Circulating Fetal Extravillous Trophoblasts Varies from Gestational Week 6 to 20
por: Ravn, Katarina, et al.
Publicado: (2020) -
Cell‐based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations
por: Hatt, Lotte, et al.
Publicado: (2020) -
Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood
por: Sunde, Lone, et al.
Publicado: (2020) -
Screening for Fetal Aneuploidy and Sex Chromosomal Anomalies in a Pregnant Woman With Mosaicism for Turner Syndrome—Applications and Advantages of Cell-Based NIPT
por: Jeppesen, Line Dahl, et al.
Publicado: (2021) -
Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls
por: Jeppesen, Line Dahl, et al.
Publicado: (2023)